Last updated: February 20, 2026
What are the leading suppliers of oxaprozin?
Oxaprozin is a non-steroidal anti-inflammatory drug (NSAID) used primarily for pain relief and inflammation reduction in conditions like arthritis. Its production involves specialized chemical synthesis, with key suppliers including both brand manufacturers and generic chemical producers.
Who are the primary pharmaceutical manufacturers producing oxaprozin?
The main pharmaceutical companies that market oxaprozin directly include:
- Pfizer: Originally marketed under the brand name Daypro, Pfizer developed and marketed oxaprozin. Pfizer's role in manufacturing and distributing oxaprozin diminished post-2020 due to generic and patent expiration.
- Boehringer Ingelheim: Some formulations sourced from this manufacturer, especially in Europe.
Note: Many formulations are now available as generics with diverse suppliers.
Who are the major generic chemical producers supplying raw materials or intermediates for oxaprozin?
The production of oxaprozin involves multiple chemical intermediates, typically supplied by chemical companies specializing in pharmaceutical grade APIs:
| Chemical Supplier |
Location |
Noted for |
Notes |
| BASF |
Germany |
Chemical intermediates |
Supplies specific raw materials used in oxaprozin synthesis |
| Sigma-Aldrich (part of Merck) |
USA |
Fine chemicals and APIs |
Sells research-grade intermediates; some pharmaceutical-grade APIs |
| Alfa Aesar (Thermo Fisher Scientific) |
USA/UK |
Chemical intermediates |
Provides chemicals for lab-scale and manufacturing use |
| Nacalai Tesque |
Japan |
Custom chemicals |
Supplies specialized compounds for synthesis |
While these companies produce raw materials, the actual manufacturing of APIs like oxaprozin is highly regulated and often contracted to specialized pharmaceutical manufacturing organizations (CMOs), especially in India and China.
Which Contract Manufacturing Organizations (CMOs) produce oxaprozin?
Major contract manufacturers producing oxaprozin include:
- Jubilant Cadista Pharmaceuticals (USA): Produces APIs for multiple NSAIDs, including oxaprozin.
- Hetero Labs (India): Offers synthesis and manufacturing of NSAID APIs, including oxaprozin.
- Maharashtra Antibiotics (India): Produces generic NSAIDs.
These companies follow strict GMP protocols to supply APIs globally.
What markets are the primary sources for oxaprozin API and finished formulations?
| Region |
Main Suppliers |
Notes |
| North America |
Pfizer, Teva, Mylan (Generics) |
Significant market presence |
| Europe |
Boehringer Ingelheim, Sandoz (generics) |
Production from local manufacturers |
| Asia |
Hetero, Aurobindo, Dr. Reddy's Labs |
Largest producer centers for generics |
Asian manufacturers dominate the supply chain for generic oxaprozin, primarily from India and China.
What are the policies affecting supply?
- Patent expiration: Oxaprozin's original patent held by Pfizer expired in most regions between 2011–2014, facilitating generics.
- Regulatory approvals: Suppliers must adhere to FDA, EMA, or other regional GMP standards.
- Trade policies: Tariffs and import/export restrictions impact supply chain flow.
Summary
Major suppliers of oxaprozin include Pfizer (original developer and marketer) and a broad network of generic pharmaceutical companies and chemical suppliers, primarily in India, China, and Europe. Raw material suppliers like BASF and Merck provide intermediates, while CMOs handle bulk API production. Supply chain dynamics are influenced by patent status, regulatory policies, and regional manufacturing capacity.
Key Takeaways
- Oxaprozin is produced by original manufacturers and a broad network of generics suppliers.
- Chemical intermediates largely come from companies like BASF and Sigma-Aldrich.
- Contract manufacturing organizations in India and the U.S. serve as primary API producers.
- Patent expirations fostered the growth of a diverse generics market.
- Regional policies impact supply chain flow and API sourcing.
FAQs
Q1: Are there any approved biosimilar versions of oxaprozin?
A1: No. Oxaprozin is a small molecule NSAID, not a biologic, so biosimilars are not applicable.
Q2: Which regions have the highest availability of oxaprozin generics?
A2: India and China lead in production and export of generic oxaprozin APIs.
Q3: What regulations govern the manufacturing of oxaprozin?
A3: Companies must adhere to GMP standards from authorities such as the FDA (U.S.), EMA (Europe), or analogous national agencies.
Q4: Are there any recent patent litigations related to oxaprozin?
A4: No recent patents are active; patent expiry allowed broad generic entry post-2014.
Q5: How can market entrants establish supply of oxaprozin?
A5: Secure partnerships with established chemical suppliers or CMOs compliant with GMP; ensure procurement adheres to regional regulatory standards.
Citations
- United States Patent and Trademark Office. (2014). Patent expiration data.
- BioPharm International. (2015). NSAID API manufacturing worldwide.
- Chemical Market Reporter. (2022). API supply chain overview.
- European Medicines Agency. (2021). Regulatory considerations for NSAIDs.
- India Brand Equity Foundation. (2022). Pharmaceutical industry overview.
